About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Tcf7l2
transcription factor 7 like 2, T cell specific, HMG box
MGI:1202879
89 phenotypes from 16 alleles in 11 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Tcf7l2em1Nobr/Tcf7l2+
involves: CD-1
decreased body weight J:175874
decreased circulating glucose level J:175874
decreased circulating insulin level J:175874
decreased lean body mass J:175874
decreased locomotor activity J:175874
decreased total body fat amount J:175874
normal homeostasis/metabolism phenotype J:175874
hypoglycemia J:175874
improved glucose tolerance J:175874
polyphagia J:175874
Tcf7l2em1Nobr/Tcf7l2em1Nobr
involves: CD-1
absent gastric milk in neonates J:175874
decreased birth body size J:175874
hypoglycemia J:175874
neonatal lethality, complete penetrance J:175874
Tcf7l2em2Nobr/Tcf7l2+
involves: CD-1
decreased body weight J:175874
decreased circulating glucose level J:175874
decreased circulating insulin level J:175874
decreased lean body mass J:175874
decreased locomotor activity J:175874
decreased total body fat amount J:175874
normal homeostasis/metabolism phenotype J:175874
hypoglycemia J:175874
improved glucose tolerance J:175874
polyphagia J:175874
Tcf7l2em2Nobr/Tcf7l2em2Nobr
involves: CD-1
absent gastric milk in neonates J:175874
decreased birth body size J:175874
hypoglycemia J:175874
neonatal lethality, complete penetrance J:175874
Tcf7l2em3Nobr/Tcf7l2em3Nobr
involves: CD-1
absent gastric milk in neonates J:175874
decreased birth body size J:175874
hypoglycemia J:175874
neonatal lethality, complete penetrance J:175874
Tcf7l2m1Btlr/Tcf7l2m1Btlr
C57BL/6J-Tcf7l2m1Btlr
increased susceptibility to induced colitis J:267536
Tcf7l2tm1(EGFP/cre)Mrc/Tcf7l2tm2.1Mrc
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl
abnormal crypts of Lieberkuhn morphology J:170088
decreased body size J:170088
normal neoplasm J:170088
Tcf7l2tm1.1(EGFP/cre)Mrc/Tcf7l2tm1.1(EGFP/cre)Mrc
involves: 129S1/Sv * 129X1/SvJ
abnormal colon goblet cell morphology J:170088
abnormal colon morphology J:170088
abnormal crypts of Lieberkuhn morphology J:170088
abnormal enterocyte proliferation J:170088
abnormal intestinal enteroendocrine cell morphology J:170088
abnormal intestine morphology J:170088
abnormal small intestine goblet cell morphology J:170088
abnormal small intestine morphology J:170088
absent gastric milk in neonates J:170088
decreased birth weight J:170088
embryo tissue necrosis J:170088
neonatal lethality, complete penetrance J:170088
Tcf7l2tm1.1(EGFP/cre)Mrc/Tcf7l2tm2.1Mrc
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl
abnormal colon morphology J:170088
abnormal crypts of Lieberkuhn morphology J:170088
abnormal enterocyte proliferation J:170088
abnormal intestinal enteroendocrine cell morphology J:170088
abnormal intestinal goblet cell morphology J:170088
abnormal intestine morphology J:170088
abnormal small intestine morphology J:170088
absent gastric milk in neonates J:170088
decreased birth weight J:170088
embryo tissue necrosis J:170088
neonatal lethality, complete penetrance J:170088
Tcf7l2tm1.1(EGFP/cre)Mrc/Tcf7l2tm2.2Mrc
involves: 129S1/Sv * 129X1/SvJ
abnormal colon morphology J:170088
abnormal crypts of Lieberkuhn morphology J:170088
abnormal enterocyte proliferation J:170088
abnormal intestinal enteroendocrine cell morphology J:170088
abnormal intestinal goblet cell morphology J:170088
abnormal intestine morphology J:170088
abnormal small intestine morphology J:170088
absent gastric milk in neonates J:170088
decreased birth weight J:170088
embryo tissue necrosis J:170088
neonatal lethality, complete penetrance J:170088
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2+
C57BL/6-Tcf7l2tm1a(EUCOMM)Wtsi
abnormal glucose homeostasis J:190447
abnormal hepatocyte physiology J:190447
abnormal response/metabolism to endogenous compounds J:190447
impaired glucose tolerance J:190447
increased circulating glucose level J:190447
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2+
C57BL/6N-Tcf7l2tm1a(EUCOMM)Wtsi/Wtsi
decreased total body fat amount J:211773
increased bone mineral content J:211773
increased bone mineral density J:211773
increased lean body mass J:211773
increased mean platelet volume J:211773
increased red blood cell distribution width J:211773
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2tm1a(EUCOMM)Wtsi
C57BL/6-Tcf7l2tm1a(EUCOMM)Wtsi
lethality, complete penetrance J:190447
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2tm1a(EUCOMM)Wtsi
C57BL/6N-Tcf7l2tm1a(EUCOMM)Wtsi/Wtsi
abnormal basilar artery morphology J:239583
abnormal cecum position J:239583
abnormal elbow joint morphology J:239583
abnormal eye muscle morphology J:239583
abnormal forebrain morphology J:239583
abnormal inferior vena cava morphology J:239583
abnormal inferior vena cava topology J:239583
abnormal Mullerian duct morphology J:239583
abnormal nasal septum morphology J:239583
abnormal neurohypophysis morphology J:239583
abnormal pulmonary valve cusp morphology J:239583
abnormal umbilical vein topology J:239583
abnormal ureter topology J:239583
abnormal vertebral artery morphology J:239583
abnormal vertebral artery topology J:239583
abnormal Wolffian duct morphology J:239583
absent ductus venosus valve J:239583
absent kidney J:239583
basisphenoid bone foramen J:239583
common truncal valve J:239583
dilated liver sinusoidal space J:239583
double outlet right ventricle J:239583
duplication of ductus venosus J:239583
fusion of vertebral arches J:239583
heterochrony J:239583
muscular ventricular septal defect J:239583
perimembraneous ventricular septal defect J:239583
preweaning lethality, complete penetrance J:211773
retroesophageal right subclavian artery J:239583
symmetric azygos veins J:239583
vertebral fusion J:239583
Tcf7l2tm1Cle/Tcf7l2tm1Cle
involves: 129P2/OlaHsd
abnormal craniofacial development J:86317
abnormal enterocyte morphology J:48968
abnormal intestinal epithelium morphology J:48968
abnormal pituitary intermediate lobe morphology J:86317
normal cellular phenotype J:98680
decreased enterocyte cell number J:48968
enlarged adenohypophysis J:86317
enlarged pituitary gland J:86317
neonatal lethality, complete penetrance J:48968
Tcf7l2tm1Geno/Tcf7l2tm1Geno
Tg(Pdx1-cre)89.1Dam/0
involves: C57BL/6 * CBA
decreased insulin secretion J:189204
decreased pancreatic beta cell mass J:189204
impaired glucose tolerance J:189204
increased circulating insulin level J:189204
Tcf7l2tm2.1Cle/Tcf7l2tm2.1Cle
Tg(Vil1-cre/ERT2)23Syr/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
abnormal enterocyte proliferation J:185753
abnormal intestine development J:185753
abnormal small intestine goblet cell morphology J:185753
absent Paneth cells J:185753
decreased Paneth cell number J:185753
ectopic Paneth cells J:185753
increased enterocyte apoptosis J:185753
Tcf7l2tm2.2Mrc/Tcf7l2tm2.2Mrc
involves: 129S1/Sv
abnormal colon morphology J:170088
abnormal crypts of Lieberkuhn morphology J:170088
abnormal enterocyte proliferation J:170088
abnormal intestinal enteroendocrine cell morphology J:170088
abnormal intestinal goblet cell morphology J:170088
abnormal intestine morphology J:170088
abnormal small intestine morphology J:170088
absent gastric milk in neonates J:170088
decreased birth weight J:170088
embryo tissue necrosis J:170088
neonatal lethality, complete penetrance J:170088
Tg(Krt14-Tcf7l2)1Efu/0
Not Specified
abnormal epidermal layer morphology J:155012
eyelids open at birth J:155012
Tg(Krt14-Tcf7l2*)2Efu/0
Not Specified
eyelids open at birth J:155012
Tg(Krt14-Tcf7l2*)3Efu/0
Not Specified
no abnormal phenotype detected J:155012
Tg(RP11-466I19/Tcf7l2)1Nobr/0
involves: CD-1
decreased food intake J:175874
normal homeostasis/metabolism phenotype J:175874
impaired glucose tolerance J:175874

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory